Dicerna Pharmaceuticals, Inc. Information Request Form
Company
Dicerna Pharmaceuticals, Inc.
Ticker
DRNA
Levi & Korsinsky announces it has commenced an investigation ofDicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) concerning possible breaches of fiduciary duty.
To receive more information, please fill out the form.